1. Home
  2. DCI vs RGEN Comparison

DCI vs RGEN Comparison

Compare DCI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCI
  • RGEN
  • Stock Information
  • Founded
  • DCI 1915
  • RGEN 1981
  • Country
  • DCI United States
  • RGEN United States
  • Employees
  • DCI N/A
  • RGEN N/A
  • Industry
  • DCI Pollution Control Equipment
  • RGEN Medical/Dental Instruments
  • Sector
  • DCI Industrials
  • RGEN Health Care
  • Exchange
  • DCI Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • DCI 8.7B
  • RGEN 7.6B
  • IPO Year
  • DCI 1987
  • RGEN N/A
  • Fundamental
  • Price
  • DCI $68.28
  • RGEN $156.55
  • Analyst Decision
  • DCI Hold
  • RGEN Buy
  • Analyst Count
  • DCI 4
  • RGEN 12
  • Target Price
  • DCI $74.00
  • RGEN $187.44
  • AVG Volume (30 Days)
  • DCI 582.4K
  • RGEN 470.1K
  • Earning Date
  • DCI 02-26-2025
  • RGEN 02-19-2025
  • Dividend Yield
  • DCI 1.59%
  • RGEN N/A
  • EPS Growth
  • DCI 16.62
  • RGEN N/A
  • EPS
  • DCI 3.44
  • RGEN N/A
  • Revenue
  • DCI $3,640,100,000.00
  • RGEN $633,513,000.00
  • Revenue This Year
  • DCI $5.29
  • RGEN $2.28
  • Revenue Next Year
  • DCI $5.19
  • RGEN $9.88
  • P/E Ratio
  • DCI $19.85
  • RGEN N/A
  • Revenue Growth
  • DCI 6.13
  • RGEN N/A
  • 52 Week Low
  • DCI $62.77
  • RGEN $113.50
  • 52 Week High
  • DCI $78.95
  • RGEN $211.13
  • Technical
  • Relative Strength Index (RSI)
  • DCI 42.87
  • RGEN 60.07
  • Support Level
  • DCI $66.01
  • RGEN $149.15
  • Resistance Level
  • DCI $69.09
  • RGEN $160.64
  • Average True Range (ATR)
  • DCI 1.11
  • RGEN 5.96
  • MACD
  • DCI 0.20
  • RGEN 0.91
  • Stochastic Oscillator
  • DCI 73.70
  • RGEN 79.57

About DCI Donaldson Company Inc.

Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.6 billion in revenue and $544 million in operating income in its fiscal 2024.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: